http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2424806-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f830084d4073b09b2da08e237cca685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c870d9e34a7c2879f2fb403ef288fe1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40960190e37af1e3390c21a67554f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18eaccafca56224cb698c158adfb3ea6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
filingDate 2010-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd56dd1c146ab63ef976030935794c25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ae4a8e8b75c27b90be1454e0571222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75483c4876219e540cb6d56763f92df
publicationDate 2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2424806-C1
titleOfInvention Method of determining efficiency of treatment of uterine body cancer
abstract FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to medicine, namely to oncology, and can be used for determining efficiency of treatment of uterine body cancer. Method includes determination of cortisol and tetrahydro-11-deoxycortisol level in day urine 1.5-2 weeks after finishing treatment. Coefficient of ratio of tetrahydro-11-deoxycortisol to cortisol is determined; if ratio value is lower than two, duration of recurrence-free period 5 or more years is predicted, and if ratio is higher than two - development of recurrence in the nearest two years. ^ EFFECT: application of invention makes it possible to select the most efficient preventive therapeutic impact and eliminate additional toxic action of chemical medications. ^ 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2618408-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2762493-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2712307-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2508550-C2
priorityDate 2010-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732582

Total number of triples: 27.